WASHINGTON - Evolent Health, Inc. (NYSE: EVH), a health outcomes company currently trading near its 52-week low at $10.21, today announced the appointment of Richard "Rick" Jelinek as its new Chair of ...

Chicago Partners Investment Group LLC boosted its position in shares of Evolent Health, Inc. (NYSE:EVH – Free Report) by 50.0 ...

13 analysts have shared their evaluations of Evolent Health EVH during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of ...

TD Cowen analyst Charles Rhyee assigned a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of $14.00.Invest ...

Evolent Health (NYSE:EVH) rose 1.3% after activist investor Engaged Capital reached a cooperation agreement with the healthcare services company. Evolent (NYSE:EVH) will add Brendan Springstubb to ...

Evolent Health, Inc. (NYSE: NYSE:EVH), a provider of healthcare delivery and payment solutions, has been navigating a complex landscape of opportunities and challenges in recent months. Trading near ...

Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to its Board of Directors as part of ...

WASHINGTON, Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced ...

Analyst Richard Close of Canaccord Genuity maintained a Buy rating on Evolent Health (EVH – Research Report), retaining the price target of $23.00. Discover outperforming stocks and invest ...